ALXA Financial Facts

Interest expense: -2.23M
Revenue: 705K
See Full Income Statement

Additional paid-in-capital: 359.7M
Total current assets: 27.26M
See Full Balance Sheet

Alexza Pharmaceuticals Inc. (ALXA) Earnings

  |   Expand Research on ALXA
Next EPS Date 8/6/15 EPS Growth Rate -76.5%
Average EPS % Beat Rate +40.1% Revenue Growth Rate -0.7%
Average % Move 1-Wk after EPS -16.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
8/6/15 Q215 N/A-$0.60 N/A N/A$1.49M N/A N/A N/A
5/6/15 Q115 -$0.02-$0.51 +$0.49$705K$3.36M N/A Details
3/9/15 Q414 -$0.35-$0.68 +$0.33$1.45B$1.3M N/A Details
8/7/14 Q214 -$0.34-$0.67 +$0.33$1.5M$2.24M N/A Details
11/6/13 Q313 -$0.72-$0.54 -$0.18$2.2M$1.98M N/A Details
8/8/13 Q213 -$0.21$0.09 -$0.30$40.84M$14.17M N/A Details
5/14/13 Q113 -$1.31-$0.45 -$0.86$729K$1M N/A Details
3/26/13 Q412 -$0.65N/A N/A $729K$1.88M N/A Details